| Financier | Commitments |
|---|---|
| IDA Credit | 40.20 |
Mauritania COVID-19 Strategic Preparedness and Response Project (SPRP)
Abstract*
The development objective of COVID-19 (Coronavirus) Strategic Preparedness and Response Project for Mauritania is to prevent, detect and respond to the threat posed by COVID-19 (Coronavirus) and strengthen national systems for public health preparedness. This project has two components. 1) The first component, Emergency COVID-19 (Coronavirus) Response, aims to slow down and limit as much as possible the spread of COVID-19 (Coronavirus) in the country... Show More
Development Objective
To strengthen the national public health preparedness capacity to prevent, detect and respond to the COVID-19 pandemic in Mauritania
Key Details
Project Details
P173837
Closed
Kazumi Inden
Islamic Republic of Mauritania
March 25, 2020
(as of board presentation)
April 2, 2020
April 6, 2020
US$ 5.20 million
Ministry of Health
2020
US$ 40.20 million
N/A
Substantial
December 31, 2024
No
BANK APPROVED
June 10, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 40.20 |
| IBRD + IDA Commitment | 40.20 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 5.20 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Apr 9, 2024 | IDA-70310 | Loan Disb | 1,400,000.00 |
| Aug 27, 2020 | IDA-D5990 | Loan Disb | 240,305.98 |
| Dec 18, 2020 | IDA-D5990 | Loan Disb | 378,587.75 |
| Oct 7, 2020 | IDA-D5990 | Loan Disb | 123,178.57 |
| Nov 12, 2020 | IDA-D5990 | Loan Disb | 500,000.00 |
| Nov 9, 2020 | IDA-D5990 | Loan Disb | 155,626.31 |
| Mar 18, 2021 | IDA-D5990 | Loan Disb | 82,449.30 |
| Jun 11, 2021 | IDA-D5990 | Loan Disb | 14,431.36 |
| Jun 4, 2021 | IDA-D5990 | Loan Disb | 511,002.50 |
| Jul 23, 2021 | IDA-D5990 | Loan Disb | 4,833.01 |
| Jan 19, 2021 | IDA-D5990 | Loan Disb | 72,229.06 |
| Nov 17, 2020 | IDA-D5990 | Loan Disb | 285,603.80 |
| Jul 20, 2020 | IDA-D5990 | Loan Disb | 285,979.53 |
| Sep 2, 2020 | IDA-D5990 | Loan Disb | 400,306.28 |
| Apr 29, 2020 | IDA-D5990 | Loan Disb | 500,000.00 |
| Nov 20, 2020 | IDA-D5990 | Loan Disb | 234,444.95 |
| Dec 4, 2020 | IDA-D5990 | Loan Disb | 501,724.12 |
| May 9, 2023 | IDA-D5990 | Loan Disb | 135,456.97 |
| Jan 31, 2023 | IDA-D8990 | Loan Disb | 102,882.62 |
| Jun 14, 2023 | IDA-D8990 | Loan Disb | 396,178.84 |
| Aug 10, 2023 | IDA-D8990 | Loan Disb | 56,848.44 |
| Jul 7, 2022 | IDA-D8990 | Loan Disb | 1,491,840.00 |
| Jul 7, 2022 | IDA-D8990 | Loan Disb | 1,820,784.40 |
| Jul 7, 2022 | IDA-D8990 | Loan Disb | 787,320.00 |
| Jul 21, 2022 | IDA-D8990 | Loan Disb | 286,661.38 |
| Jun 30, 2022 | IDA-D8990 | Loan Disb | 201,600.00 |
| Jun 23, 2022 | IDA-D8990 | Loan Disb | 365,896.34 |
| Mar 9, 2022 | IDA-D8990 | Loan Disb | 1,169,736.80 |
| Nov 22, 2022 | IDA-D8990 | Loan Disb | 300,966.60 |
| Jan 21, 2022 | IDA-D8990 | Loan Disb | 379,898.70 |
| Apr 26, 2021 | IDA-D5990 | Loan Disb | 66,406.95 |
| Apr 26, 2021 | IDA-D5990 | Loan Disb | 467,862.88 |
| Aug 18, 2021 | IDA-D5990 | Loan Disb | 46,716.98 |
| Jun 23, 2022 | IDA-D8990 | Loan Disb | 934,477.50 |
| Jun 23, 2022 | IDA-D8990 | Loan Disb | 533,169.00 |
| Oct 12, 2021 | IDA-D8990 | Loan Disb | 1,400,000.00 |
| May 31, 2023 | IDA-D8990 | Loan Disb | 41,156.20 |
| Jul 13, 2023 | IDA-D5990 | Loan Disb | 436,486.50 |
| Jul 18, 2023 | IDA-D8990 | Loan Disb | 188,710.39 |
| Jun 12, 2023 | IDA-D8990 | Loan Disb | 39,717.41 |
| Jul 5, 2023 | IDA-D5990 | Loan Disb | -402,032.72 |
| Sep 14, 2023 | IDA-D8990 | Loan Disb | 299,266.72 |
| Apr 12, 2024 | IDA-D8990 | Loan Disb | 2.86 |
| Jan 12, 2024 | IDA-D8990 | Loan Disb | 441,168.94 |
| Jan 8, 2024 | IDA-D8990 | Loan Disb | 273,456.34 |
| Apr 12, 2023 | IDA-D8990 | Loan Disb | 78,622.45 |
| Oct 6, 2022 | IDA-D8990 | Loan Disb | 218,560.84 |
| Sep 6, 2022 | IDA-D8990 | Loan Disb | 309,022.34 |
| Sep 6, 2022 | IDA-D8990 | Loan Disb | 698,002.00 |
| Oct 11, 2022 | IDA-D8990 | Loan Disb | 198,848.73 |
| Dec 23, 2021 | IDA-70310 | Loan Commitment | 20,000,000.00 |
| Jun 30, 2021 | IDA-D8990 | Loan Commitment | 15,000,000.00 |
| Apr 2, 2020 | IDA-D5990 | Loan Commitment | 5,200,000.00 |
| Oct 10, 2023 | IDA-D8990 | Loan Disb | 108,598.24 |
| Nov 17, 2023 | IDA-D8990 | Loan Disb | 387,057.20 |
| Jul 31, 2024 | IDA-D8990 | Loan Disb | -18,216.53 |
| Apr 9, 2024 | IDA-D5990 | Loan Disb | 219,871.67 |
| Mar 18, 2024 | IDA-D8990 | Loan Disb | 192,733.56 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Moderately Satisfactory | 2025-03-11 |
| Project Management | Moderately Satisfactory | 2025-03-11 |
| Monitoring and Evaluation | Moderately Satisfactory | 2025-03-11 |
| Procurement | Moderately Satisfactory | 2025-03-11 |
| Financial Management | Satisfactory | 2025-03-11 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2025-03-11 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Suspected cases of COVID-19 reported and investigated per approved protocol (by sex) Value 40.00 100.00 100.00 Date March 19, 2020 June 5, 2024 December 31, 2024 Comment By sex Value 0.00 100.00 100.00 Date March 19, 2020 June 5, 2024 December 31, 2024 Comment Health facilities with trained staff in Covid-19 infection prevention control per MoH approved protocol Value 85.00 100.00 90.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment Reference and district hospitals with personal protective equipment and infection control products and supplies, without stock-outsin preceding two weeks Value 0.00 88.90 80.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment ICU beds in prioritized ICU units that are fully equipped and operational for COVID-19 response Value 0.00 74.00 90.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment Population in the priority group fully vaccinated Value 0.00 35.30 20.00 Date June 21, 2021 June 5, 2024 December 31, 2024 Comment By sex Value 0.00 39.84 40.00 Date March 1, 2021 June 5, 2024 December 31, 2024 Comment Target population fully vaccinated Value 0.00 53.44 80.00 Date February 1, 2021 June 5, 2024 December 31, 2024 Comment By sex Value 0.00 45.90 50.00 Date February 1, 2021 June 5, 2024 December 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Border control sites with trained teams and the necessary means of control, isolation and transport to isolation and care sites Value 0.00 32.00 32.00 Date March 22, 2020 June 5, 2024 December 31, 2024 Comment Reference and district hospitals have submitted complete monthly reports on the number of suspected cases identified, tested and contacts traced Value 0.00 100.00 90.00 Date March 19, 2020 June 5, 2024 December 31, 2024 Comment Priority healthcare facilities that received protective equipment and hygiene materials Value 0.00 100.00 100.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment Complaints to the GRM satisfactorily addressed within 15 weeks of initial complaint being recorded Value 0.00 0.00 70.00 Date January 29, 2021 June 5, 2024 December 31, 2024 Comment Laboratory-confirmed cases of COVID-19 responded to within 48 hours Value 0.00 100.00 100.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment Vaccination sites that use the digital vaccination platform for data entry, analysis and reporting Value 0.00 100.00 50.00 Date February 1, 2021 June 5, 2024 December 31, 2024 Comment Designated laboratories fully equipped with COVID-19 diagnostic equipment, test kits, and reagents per MOH guidelines Value 0.00 100.00 100.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment Guidelines, documented procedures, and tools for planning and conducting vaccine pharmacovigilance activities are established and available Value No Yes Yes Date July 30, 2021 June 5, 2024 April 30, 2023 Comment Isolation centers, screening sites and quarantine centers established and equipped with medical supplies and protective equipments in all regions covered by the project Value 0.00 100.00 100.00 Date March 20, 2020 June 5, 2024 December 31, 2024 Comment COVID-19 vaccine delivery strategies to reach identified target groups are defined Value No Yes Yes Date June 21, 2021 June 5, 2024 April 30, 2023 Comment Community engagement plan developed for increasing demand creation for the COVID-19 vaccine by the population. Value No Yes Yes Date June 21, 2021 June 5, 2024 April 30, 2023 Comment Functional mechanisms to capture community feedback are established (for example, community meetings, hotlines, health volunteer network, social listening, surveys, and so on). Value No Yes Yes Date June 21, 2021 June 5, 2024 April 30, 2023 Comment SOPs or guidelines established for collection and disposal of medical waste to the relevant stakeholders. Value No Yes Yes Date June 21, 2021 June 5, 2024 April 30, 2023 Comment Health care providers trained to recognize early signs of gender-based violence Value 0.00 127.00 100.00 Date November 1, 2021 June 5, 2024 December 31, 2024 Comment Health centers that provide psychosocial services to GBV survivors Value 0.00 39.00 20.00 Date November 1, 2021 June 5, 2024 December 31, 2024 Comment